Results 151 to 160 of about 565 (181)
Some of the next articles are maybe not open access.

Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies.

Bollettino dell'Istituto sieroterapico milanese, 1984
We have compared ELISA and IFA for the quantitation of IgG and IgM antitoxoplasma antibodies on whole sera and purified IgM fractions. In all the sera examined from adult patients the good correspondence of the two tests is expressed by a correlation coefficient of 0.77 (p = 0.001). However, we have observed that both IgM-ELISA and IgM-IFA performed on
Filice, G   +4 more
openaire   +1 more source

The antitoxoplasma gondii antibodies incidence to the different ocular diseases patients cases of human ocular toxoplasmosis infections in Romania.

Oftalmologia (Bucharest, Romania : 1990), 2009
Toxoplasmosis is an anthropo-zoonosis widely spread around the earth, whose ocular complications are very frequent and are often a first sign of infestation. This is a retrospective statistic research based on the clinical survey and periodic control of a lot of 135 patients with toxoplasmosis, out of which 90 presented ocular toxoplasmosis.
Cristina, Teodorescu   +4 more
openaire   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Avidity in antibody effector functions and biotherapeutic drug design

Nature Reviews Drug Discovery, 2022
Simone C Oostindie, Janine Schuurman
exaly  

[Research on antitoxoplasma antibodies in gynecological pathology].

Rivista di ostetricia e ginecologia, 1967
A, Piccolomini   +2 more
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel   +2 more
exaly  

Diagnostic value of fluorescent antitoxoplasma antibody in toxoplasma retinochoroiditis.

International journal of tissue reactions, 1994
S, Srimuang   +7 more
openaire   +1 more source

Next generation antibody drugs: pursuit of the 'high-hanging fruit'

Nature Reviews Drug Discovery, 2017
Paul J Carter, Gregory Lazar
exaly  

Home - About - Disclaimer - Privacy